Search
What are you looking for?
Start main content

Press Releases

Press Releases

https://www.med.cuhk.edu.hk/press-releases/cuhk-hku-collaborative-study-finds-about-80-lower-risk-of-death-among-covid-19-inpatients-prescribed-oral-medication-and-the-risk-of-hospital-admission-in-outpatients-is-significantly-reduced-by-nearly-90
https://www.med.cuhk.edu.hk/press-releases/cuhk-hku-collaborative-study-finds-about-80-lower-risk-of-death-among-covid-19-inpatients-prescribed-oral-medication-and-the-risk-of-hospital-admission-in-outpatients-is-significantly-reduced-by-nearly-90

CUHK-HKU collaborative study finds about 80% lower risk of death among COVID-19 inpatients prescribed oral medication and the risk of hospital admission in outpatients is significantly reduced by nearly 90%

Two types of oral antiviral drugs have been prescribed to COVID-19 patients since the fifth wave of the pandemic in Hong Kong. A recent study led by researchers from The Chinese University of Hong Kong (CUHK)’s Faculty of Medicine (CU Medicine) and The University of Hong Kong’s LKS Faculty of Medicine (HKUMed) revealed that the oral antiviral agent strategy may reduce the risk of death in hospitalised patients by 76%. The risk of hospital admission in outpatients was also reduced by 88%.

 

Nirmatrelvir-Ritonavir (Pfizer’s oral drug) may save over HK$43,000 by preventing one death when compared to usual methods of care. The study findings have just been published in The Lancet Regional Health – Western Pacific.

 

Analysis of data on more than 50,000 COVID-19 patients from the fifth wave

 

The Jockey Club School of Public Health and Primary Care at CU Medicine and the Department of Emergency Medicine at HKUMed conducted a retrospective cohort analysis between February and March 2022, also known as the peak of the fifth wave, involving 54,355 COVID-19 outpatients in designated clinics and inpatients in public hospitals in Hong Kong.  They evaluated the effectiveness of Molnupiravir (Merck Sharp & Dohme’s oral drug) and Nirmatrelvir-Ritonavir. The research included patients who were 60 years old or above, and patients under the age of 60 with at least one chronic disease. Among these patients, 20% were prescribed either one of the oral drugs.

 

The research team found that both Molnupiravir and Nirmatrelvir-Ritonavir were significantly associated with a reduced risk of death among inpatients. In hospitalised patients either Molnupiravir alone or Nirmatrelvir-Ritonavir prescription reduced all-cause mortality by 76%. Nirmatrelvir-Ritonavir reduced the risk of death by 90%, while Molnupiravir did so by 69%.

 

Among outpatients, prescription of Molnupiravir or Nirmatrelvir-Ritonavir lowered the risk of poor health outcome progression and unplanned hospital admissions within 28 days after attending outpatient clinics by 88%. Nirmatrelvir-Ritonavir reduced the odds for unplanned hospital admissions by 63% and Molnupiravir by 28%.

Among hospitalised patients, prescription of Molnupiravir or Nirmatrelvir-Ritonavir lowered the risk of unplanned hospital readmission within 28 days after admission to inpatient ward by 21%. Nirmatrelvir-Ritonavir had a significantly better reduction of 53% than Molnupiravir’s 29%. 

 

Nirmatrelvir-Ritonavir saved over HK$43,000 to prevent one death, compared to usual methods of care
 

The research team also calculated the cost of preventing one death when compared to usual methods of care. In inpatient settings, Nirmatrelvir-Ritonavir saved HK$43,194 (US$5,503) to prevent one death, while Molnupiravir cost an extra HK$20,637 (US$2,629) to do so[1].

 

The research team pointed out that, although Nirmatrelvir-Ritonavir is more effective in reducing death risk and hospital admission, it has significant drug-drug interaction potential and may not be suitable for some patients who are taking blood thinners or antibiotics. The potential for Molnupiravir to interact with concomitant medications is considered low.

 

A triage mechanism may be worth considering for timely prescription of oral antiviral agents to COVID-19 patients with mild to moderate symptoms

 

Dr Crystal Chan Ying, co-first author of the study and Postdoctoral Fellow from The Jockey Club School of Public Health and Primary Care at CU Medicine, said, “In COVID-19 patients with mild symptoms, both Molnupiravir and Nirmatrelvir-Ritonavir prescriptions were associated with reduced all-cause mortality and healthcare utilisation, while Nirmatrelvir-Ritonavir was associated with significant cost savings in inpatient settings.”

 

Professor Eliza Wong Lai-yi, co-corresponding author of the study from The Jockey Club School of Public Health and Primary Care at CU Medicine, commented, “To ensure the sustainability of the healthcare system, it is recommended that a triage mechanism should be in place to refer COVID-19 patients with mild to moderate symptoms to designated clinics or collaborating general practitioners for timely prescription of oral antiviral agents.”

 

Importance of a real-world prescription data for timely prescription of oral antiviral agents to COVID-19 patients with mild to moderate symptoms
 

Co-first author of the study, Dr Abraham Wai Ka-chung, Clinical Assistant Professor from the HKUMed’s Department of Emergency Medicine and Consultant at The University of Hong Kong-Shenzhen Hospital (HKU-SZH), said, “This study examines the real-world prescription data about both Molnupiravir, Nirmatrelvir-Ritonavir and conservative management in wards, emergency departments and clinics. Timely treatment with these antiviral agents effectively protects our senior citizens and patients with chronic diseases infected with Omicron variant from hospitalisation and death. Our clinical and health economic analyses should inform the policy makers the direction of territory-wide infection management strategy.”

 

The other co-corresponding author, Professor Timothy Rainer from the HKUMed’s Department of Emergency Medicine, added, “This study deals with associations rather than cause and effect.  Its findings suggest that these antivirals may save lives and costs but they need validation in clinical trials.  In the absence of such trials, these data may cautiously and temporarily guide policy in the short term.”

 

[1] Cost-effectiveness of antivirals was estimated considering the 1) antiviral medication costs (Molnupiravir: USD306.40, Nirmatrelvir-ritonavir: USD205.94); 2) inpatient health care cost and the mean length-of-stay (Molnupiravir 9.97 days; Nirmatrelvir-ritonavir: 8.92 days) and 3) subsequent emergency department visit (Molnupiravir: reduce 29%; Nirmatrelvir-ritonavir: reduce 53%; average cost per ED visit: USD156.7).

 

Appendix

 

Table 1: Details of the study results

 

 

Prescription of

Molnupiravir or Nirmatrelvir-Ritonavir

 

Prescription of

Molnupiravir

 

 

 

Prescription of

Nirmatrelvir-Ritonavir

 

 

Reduction in the risk of death in inpatients

76%

69%

90%

Reduction of hospital admission within 28 days after attending outpatient clinics

88%

 

 

28%

 

63%

 

Reduction of hospital re-admission within 28 days after admission to inpatient ward

21%

29%

53%

Healthcare cost per death adverted in comparison with usual methods of care

/

 

 

HK$20,637 extra

 

HK$43,194 saved

More Press Releases

CUHK study advises residential care homes for the elderly to maintain current infection control practices

CUHK study advises residential care homes for the elderly to maintain current infection control practices

Research
CUHK develops a real-time bioinformatics platform to predict COVID-19 vaccine effectiveness against SARS-CoV-2 variants with 95% accuracy

CUHK develops a real-time bioinformatics platform to predict COVID-19 vaccine effectiveness against SARS-CoV-2 variants with 95% accuracy

Research
HKUMed-CU Medicine joint study shows that vaccinated individuals develop more robust and broadly reactive antibody responses against SARS-CoV-2 variants than the unvaccinated after an Omicron infection

HKUMed-CU Medicine joint study shows that vaccinated individuals develop more robust and broadly reactive antibody responses against SARS-CoV-2 variants than the unvaccinated after an Omicron infection

Research
CU Medicine Survey Shows Only 25% of Unvaccinated People Intend to Get Inoculated in the Coming Six Months “Multiple Incentives” are Urgently Needed

CU Medicine Survey Shows Only 25% of Unvaccinated People Intend to Get Inoculated in the Coming Six Months “Multiple Incentives” are Urgently Needed

Research
CU Medicine Estimates 20,000 COVID-19 Hidden Infections in Hong Kong  All Vaccinated Persons in HK Developed Neutralising Antibody After Two Doses  Urgent Call for the Largely Unprotected Population to Get Vaccinated

CU Medicine Estimates 20,000 COVID-19 Hidden Infections in Hong Kong All Vaccinated Persons in HK Developed Neutralising Antibody After Two Doses Urgent Call for the Largely Unprotected Population to Get Vaccinated

Research
CU Medicine Survey Shows Government Recommendation as the Strongest Driver for COVID-19 Vaccine Acceptance

CU Medicine Survey Shows Government Recommendation as the Strongest Driver for COVID-19 Vaccine Acceptance

Research
CUHK Study Shows Exposure Settings Impact COVID-19 Transmission With Entertainment Setting Showing Propensity for Widespread Dispersion

CUHK Study Shows Exposure Settings Impact COVID-19 Transmission With Entertainment Setting Showing Propensity for Widespread Dispersion

Research
CU Medicine Recruits 3,000 Persons to Investigate Hidden Infection and Break the Obstacles in Containing COVID-19 in Hong Kong

CU Medicine Recruits 3,000 Persons to Investigate Hidden Infection and Break the Obstacles in Containing COVID-19 in Hong Kong

Research
CU Medicine Announces the Community Response Study Results During the Early Phase of the COVID-19 Outbreak in Hong Kong

CU Medicine Announces the Community Response Study Results During the Early Phase of the COVID-19 Outbreak in Hong Kong

Research
CU Medicine launches The Jockey Club S.A.T.H. Project for Healthy Families  to enhance health management capacity of ethnic minorities

CU Medicine launches The Jockey Club S.A.T.H. Project for Healthy Families to enhance health management capacity of ethnic minorities

Donation
Large-scale clinical study shows CU Medicine (SIM01) microbiome formula reduces risk of infections including COVID-19

Large-scale clinical study shows CU Medicine (SIM01) microbiome formula reduces risk of infections including COVID-19

Research
CU Medicine supported by the Hospital Authority to launch HK’s first large-scale Long COVID survey, aiming to inform the government on impact of long COVID on healthcare services

CU Medicine supported by the Hospital Authority to launch HK’s first large-scale Long COVID survey, aiming to inform the government on impact of long COVID on healthcare services

Research
COVID-19 pandemic disrupted the daily lives of schoolchildren in Hong Kong; Proportion of overweight and obese kids more than doubled

COVID-19 pandemic disrupted the daily lives of schoolchildren in Hong Kong; Proportion of overweight and obese kids more than doubled

Research
CUHK finds that a booster vaccine dose is effective in retriggering antibodies in breast milk that protect babies

CUHK finds that a booster vaccine dose is effective in retriggering antibodies in breast milk that protect babies

Research
CUHK finds the largest rise in incidence of Hodgkin lymphoma in Asia Rising trend of male incidence means Hong Kong tops the world

CUHK finds the largest rise in incidence of Hodgkin lymphoma in Asia Rising trend of male incidence means Hong Kong tops the world

Research
CUHK study suggests COVID-19 booster shot is key to protecting against infection among high-risk populations and from variants of concern

CUHK study suggests COVID-19 booster shot is key to protecting against infection among high-risk populations and from variants of concern

Research
CUHK Clinical Trial Centre collaborates with CUHK Medical Centre to conduct Hong Kong’s first clinical trial of novel oral treatment specifically developed for COVID-19

CUHK Clinical Trial Centre collaborates with CUHK Medical Centre to conduct Hong Kong’s first clinical trial of novel oral treatment specifically developed for COVID-19

Research
CUHK researchers discover distinct gut microbial signatures for prediction, diagnosis and treatment of long COVID

CUHK researchers discover distinct gut microbial signatures for prediction, diagnosis and treatment of long COVID

Research
CU Medicine study shows a higher prevalence of dry eye disease  among post-COVID-19 patients

CU Medicine study shows a higher prevalence of dry eye disease among post-COVID-19 patients

Research
CU Medicine and Kowloon City District Office co-organise community COVID-19 vaccination programme targeting 2,000 residents, especially young children

CU Medicine and Kowloon City District Office co-organise community COVID-19 vaccination programme targeting 2,000 residents, especially young children

Health Campaign
A joint HKU-CUHK study finds that smoking  increases the risk of COVID-19

A joint HKU-CUHK study finds that smoking increases the risk of COVID-19

Research
CUHK-HKU collaborative research finds a new inflammatory activation pathway in  blood vessels after SARS-CoV-2 infection

CUHK-HKU collaborative research finds a new inflammatory activation pathway in blood vessels after SARS-CoV-2 infection

Research
CU Medicine study shows distinct gut microbial profile associated with long COVID

CU Medicine study shows distinct gut microbial profile associated with long COVID

Research
CU Medicine finds Eastern Asia’s lung cancer incidence and mortality highest in the world

CU Medicine finds Eastern Asia’s lung cancer incidence and mortality highest in the world

Research
Assessment of Omicron outbreak in Hong Kong after reimplementation of some of the toughest social distancing measures effective from 7 January

Assessment of Omicron outbreak in Hong Kong after reimplementation of some of the toughest social distancing measures effective from 7 January

Research
HKUMed-CU Medicine joint study finds that third dose of Comirnaty has better protection from COVID-19 variant Omicron

HKUMed-CU Medicine joint study finds that third dose of Comirnaty has better protection from COVID-19 variant Omicron

Research
HKUMed-CU Medicine joint study finds COVID-19 variant Omicron significantly reduces virus neutralisation ability of BioNTech vaccine

HKUMed-CU Medicine joint study finds COVID-19 variant Omicron significantly reduces virus neutralisation ability of BioNTech vaccine

Research
Joint CUHK-HKU study discovers efficacy of COVID-19 vaccines correlates with a probiotic bacterium, Bifidobacterium adolescentis

Joint CUHK-HKU study discovers efficacy of COVID-19 vaccines correlates with a probiotic bacterium, Bifidobacterium adolescentis

Research
CUHK study sheds light on novel mechanism and treatment of acute kidney injury in COVID-19 patients

CUHK study sheds light on novel mechanism and treatment of acute kidney injury in COVID-19 patients

Research
CUHK Study Suggests a Standardised Experimental Setup is the Key to Optimise  Performance of COVID-19 Nucleic Acid Tests

CUHK Study Suggests a Standardised Experimental Setup is the Key to Optimise Performance of COVID-19 Nucleic Acid Tests

Research
CUHK Study Demonstrates a 2.5-fold Increase in Myopia Incidence in Children  During COVID-19 Pandemic Due to Less Time Outdoors and More Time on Screens

CUHK Study Demonstrates a 2.5-fold Increase in Myopia Incidence in Children During COVID-19 Pandemic Due to Less Time Outdoors and More Time on Screens

Research
A Global Study Led by CU Medicine and HKUMed Discovers  a Hepatitis C Virus Drug as Potent Treatment for COVID-19

A Global Study Led by CU Medicine and HKUMed Discovers a Hepatitis C Virus Drug as Potent Treatment for COVID-19

Research
CUHK Develops a Computational Platform to Predict Vaccine Effectiveness by Virus Genome

CUHK Develops a Computational Platform to Predict Vaccine Effectiveness by Virus Genome

Research
CU Medicine Study Shows Recovered Mothers Transfer COVID-19 Antibodies to Newborn Babies

CU Medicine Study Shows Recovered Mothers Transfer COVID-19 Antibodies to Newborn Babies

Research
CU Medicine Study Suggests Toddlers are at High Risk of Being  “Silent Spreaders of SARS-CoV2 Infection”

CU Medicine Study Suggests Toddlers are at High Risk of Being “Silent Spreaders of SARS-CoV2 Infection”

Research
CU Medicine Study Shows Modulation of Gut Microbiota  Helps Enhance Safety and Efficacy of COVID-19 Vaccine

CU Medicine Study Shows Modulation of Gut Microbiota Helps Enhance Safety and Efficacy of COVID-19 Vaccine

Research
CU Medicine and International Surgeons Suggest Patients with Positive COVID-19 Results Should Delay Surgery for Seven Weeks to Reduce Death Risk

CU Medicine and International Surgeons Suggest Patients with Positive COVID-19 Results Should Delay Surgery for Seven Weeks to Reduce Death Risk

International collaboration
CUHK Study Shows Regular Exercise Is a Safe Diabetes Prevention Strategy For People Living in Polluted Regions

CUHK Study Shows Regular Exercise Is a Safe Diabetes Prevention Strategy For People Living in Polluted Regions

Research
CU Medicine Finds New Evidence for Link between Gut Microbiome and COVID-19 Severity Microbiome Imbalance Might Influence “Long COVID” Risk

CU Medicine Finds New Evidence for Link between Gut Microbiome and COVID-19 Severity Microbiome Imbalance Might Influence “Long COVID” Risk

Research
CUHK Develops Automatic Retinal Image Analysis Technology for Identifying Autism Making Objective Screening and Early Intervention Possible

CUHK Develops Automatic Retinal Image Analysis Technology for Identifying Autism Making Objective Screening and Early Intervention Possible

Research
CUHK Introduces Nasal Strip Sampling for COVID-19 Test As a Superior Tool for Surveillance in a Wide Age-Range Population

CUHK Introduces Nasal Strip Sampling for COVID-19 Test As a Superior Tool for Surveillance in a Wide Age-Range Population

Research
40% of Hong Kong People Show Gut Dysbiosis Comparable to that of COVID-19 Patients CUHK Microbiome Immunity Formula Hastens Recovery of COVID-19 Patients and Offers Hope to Boost Immunity

40% of Hong Kong People Show Gut Dysbiosis Comparable to that of COVID-19 Patients CUHK Microbiome Immunity Formula Hastens Recovery of COVID-19 Patients and Offers Hope to Boost Immunity

Research
CU Medicine Studies Highlight Smoking as a Contributing Factor for Bladder Cancer and  Develop an International Collaborative Consensus on En Bloc Resection to Treat the Disease

CU Medicine Studies Highlight Smoking as a Contributing Factor for Bladder Cancer and Develop an International Collaborative Consensus on En Bloc Resection to Treat the Disease

Research
CU Medicine Finds An Increasing Global Trend on Pancreatic Cancer among Female and Younger Individuals

CU Medicine Finds An Increasing Global Trend on Pancreatic Cancer among Female and Younger Individuals

Research
CU Medicine Found SARS-CoV2 in Infants' Stool A Coronavirus Testing Centre Is Established for Paediatric Population to Identify Silent Carriers

CU Medicine Found SARS-CoV2 in Infants' Stool A Coronavirus Testing Centre Is Established for Paediatric Population to Identify Silent Carriers

Research
Most Deaths from COVID-19 in Hong Kong are of 60 Years Old or Above CUHK Initiated International Effort in Devising Strategies to Protect Older People with Dementia amid COVID-19 Pandemic

Most Deaths from COVID-19 in Hong Kong are of 60 Years Old or Above CUHK Initiated International Effort in Devising Strategies to Protect Older People with Dementia amid COVID-19 Pandemic

Research
CU Medicine Study Shows Liver Injury is Common and Prognostic in COVID-19 Patients

CU Medicine Study Shows Liver Injury is Common and Prognostic in COVID-19 Patients

Research
CUHK Researchers Uncover Diabetes as a Potential Risk Factor for COVID-19,  and Possible Mechanisms

CUHK Researchers Uncover Diabetes as a Potential Risk Factor for COVID-19, and Possible Mechanisms

Research
CUHK Established the Institute of Health Equity Investigates Housing Affordability Effects on Physical and Mental Health

CUHK Established the Institute of Health Equity Investigates Housing Affordability Effects on Physical and Mental Health

Research
CU Medicine Survey Shows Global Urological Services have been Significantly Deferred due to COVID-19 Pandemic

CU Medicine Survey Shows Global Urological Services have been Significantly Deferred due to COVID-19 Pandemic

Research
CU Medicine Develops a Probiotic Formula to Target Imbalance in Gut Microbiota in COVID-19

CU Medicine Develops a Probiotic Formula to Target Imbalance in Gut Microbiota in COVID-19

Research
CU Medicine Offers Free Stool Screening Test for COVID-19 in Children arriving at Airport

CU Medicine Offers Free Stool Screening Test for COVID-19 in Children arriving at Airport

Clinical service
CUHK Finds that the Coronavirus Can Persist in Stool after Its Clearance in Respiratory Tract Will Conduct Stool Test for People in Quarantine Camps for Early Identification

CUHK Finds that the Coronavirus Can Persist in Stool after Its Clearance in Respiratory Tract Will Conduct Stool Test for People in Quarantine Camps for Early Identification

Research
CUHK-Jockey Club Pain Relief Project for the Seniors Preliminary Data Shows 90% of Interviewed Elderly Have at Least Two Pain Sites

CUHK-Jockey Club Pain Relief Project for the Seniors Preliminary Data Shows 90% of Interviewed Elderly Have at Least Two Pain Sites

Health Campaign
CUHK Promotes The “May Measurement Month” in Response to World Hypertension Day, Calling for Public Awareness on Blood Pressure

CUHK Promotes The “May Measurement Month” in Response to World Hypertension Day, Calling for Public Awareness on Blood Pressure

Health Campaign
Hong Kong’s waters benefit health and wellbeing

Hong Kong’s waters benefit health and wellbeing

Research
CUHK Thomas Jing Centre for Mindfulness Research and Training Established

CUHK Thomas Jing Centre for Mindfulness Research and Training Established

Research
CUHK Reveals the Key to a Successful HPV Vaccination Programme

CUHK Reveals the Key to a Successful HPV Vaccination Programme

Research
CUHK Study Shows Behavioural Activation with Mindfulness Lower Major Depression Risk

CUHK Study Shows Behavioural Activation with Mindfulness Lower Major Depression Risk

Research
Professor YEOH Eng Kiong Delivers a Talk on End-of-life Care in CUHK Medicine’s Mok Hing Yiu Lecture

Professor YEOH Eng Kiong Delivers a Talk on End-of-life Care in CUHK Medicine’s Mok Hing Yiu Lecture

Symposium
CUHK Asia’s First Comprehensive Epidemiological Study on Health Impact of Household Cleaning Products on Children Reveals Frequent Use of Household Cleaning Products Increase Risk of Triggering Rhinitis in Children

CUHK Asia’s First Comprehensive Epidemiological Study on Health Impact of Household Cleaning Products on Children Reveals Frequent Use of Household Cleaning Products Increase Risk of Triggering Rhinitis in Children

Research
CUHK Research Shows 1 in 5 Throat Cancer Patients in HK is HPV infected

CUHK Research Shows 1 in 5 Throat Cancer Patients in HK is HPV infected

Research
CUHK CGH Distinguished Lecture Series: Vision and Experience Sharing from Public Health England

CUHK CGH Distinguished Lecture Series: Vision and Experience Sharing from Public Health England

Symposium
CUHK CGH Distinguished Lecture Series: South Africa Minister of Health Spoke on Impact of Ebola Epidemic in South Africa and African Continent

CUHK CGH Distinguished Lecture Series: South Africa Minister of Health Spoke on Impact of Ebola Epidemic in South Africa and African Continent

Surgical advancement
CUHK Develops an Automatic Retinal Image Analysis System to Help Diabetes Patients and Elderly Prevent Stroke

CUHK Develops an Automatic Retinal Image Analysis System to Help Diabetes Patients and Elderly Prevent Stroke

Research
CUHK Green Pioneer Series CUHK Recommends Hong Kong's New Air Quality Objectives Should Not Ignore Coarse Particulate Pollutants

CUHK Green Pioneer Series CUHK Recommends Hong Kong's New Air Quality Objectives Should Not Ignore Coarse Particulate Pollutants

Research
CUHK Urges Widespread Helmet Use and Protective Measures Against Cycling-related Traumatic Brain Injury

CUHK Urges Widespread Helmet Use and Protective Measures Against Cycling-related Traumatic Brain Injury

Research
Opening Ceremony of International Conference on Global Health and Public Health Education and Launching of the CUHK Jockey Club Community Primary Care Programme

Opening Ceremony of International Conference on Global Health and Public Health Education and Launching of the CUHK Jockey Club Community Primary Care Programme

Symposium
Inauguration Ceremony of CCOU Centre for Disaster and Medical Humanitarian Response (CCOUC) Held Today

Inauguration Ceremony of CCOU Centre for Disaster and Medical Humanitarian Response (CCOUC) Held Today

Education
CUHK Green Pioneer Series Findings on Increasing Trend of Primary NO2 Exhaust Emission Fraction in Hong Kong

CUHK Green Pioneer Series Findings on Increasing Trend of Primary NO2 Exhaust Emission Fraction in Hong Kong

Research

Our Expert List

Many experts under the Faculty of Medicine are available for media interview.
Please click here for the expert list or contact us.